Literature DB >> 20526403

Antipsychotic use varies by patient age.

Elisa F Cascade1, Amir H Kalali, Leslie Citrome.   

Abstract

Since their introduction in mid 1990's, atypical antipsychotics have been studied in a ever-expanding number of conditions. To gain a better understanding of current practice patterns, we investigated antipsychotic uses across different patient age groups. In both the 18 to 39 and 40 to 64 age groups, schizophrenia (ICD-9 295) and affective psychoses (ICD-9 296) account for approximately 70 percent of atypical antipsychotic use. In contrast, these diagnoses only represent 41 percent of use in patients age 0 to 17 and 36 percent in patients age 65 and older.

Entities:  

Keywords:  antipsychotics; children; off label; patient age; prescriptions

Year:  2007        PMID: 20526403      PMCID: PMC2880928     

Source DB:  PubMed          Journal:  Psychiatry (Edgmont)        ISSN: 1550-5952


  9 in total

1.  National trends in the outpatient treatment of children and adolescents with antipsychotic drugs.

Authors:  Mark Olfson; Carlos Blanco; Linxu Liu; Carmen Moreno; Gonzalo Laje
Journal:  Arch Gen Psychiatry       Date:  2006-06

Review 2.  The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease.

Authors:  C Ballard; J Waite
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

3.  Patterns and determinants of antipsychotic prescribing in children and adolescents, 2003-2004.

Authors:  Rajender R Aparasu; Vinod Bhatara
Journal:  Curr Med Res Opin       Date:  2007-01       Impact factor: 2.580

Review 4.  Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents.

Authors:  Christoph U Correll; Harold E Carlson
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2006-07       Impact factor: 8.829

5.  Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients.

Authors:  Sebastian Schneeweiss; Soko Setoguchi; Alan Brookhart; Colin Dormuth; Philip S Wang
Journal:  CMAJ       Date:  2007-02-27       Impact factor: 8.262

6.  Risk of death in elderly users of conventional vs. atypical antipsychotic medications.

Authors:  Philip S Wang; Sebastian Schneeweiss; Jerry Avorn; Michael A Fischer; Helen Mogun; Daniel H Solomon; M Alan Brookhart
Journal:  N Engl J Med       Date:  2005-12-01       Impact factor: 91.245

7.  Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials.

Authors:  Lon S Schneider; Karen S Dagerman; Philip Insel
Journal:  JAMA       Date:  2005-10-19       Impact factor: 56.272

8.  Neither atypical nor conventional antipsychotics increase mortality or hospital admissions among elderly patients with dementia: a two-year prospective study.

Authors:  Minna M Raivio; Jouko V Laurila; Timo E Strandberg; Reijo S Tilvis; Kaisu H Pitkälä
Journal:  Am J Geriatr Psychiatry       Date:  2007-05       Impact factor: 4.105

9.  Antipsychotic drug use and mortality in older adults with dementia.

Authors:  Sudeep S Gill; Susan E Bronskill; Sharon-Lise T Normand; Geoffrey M Anderson; Kathy Sykora; Kelvin Lam; Chaim M Bell; Philip E Lee; Hadas D Fischer; Nathan Herrmann; Jerry H Gurwitz; Paula A Rochon
Journal:  Ann Intern Med       Date:  2007-06-05       Impact factor: 25.391

  9 in total
  1 in total

1.  Alzheimer's therapies.

Authors:  Elisa F Cascade; Amir H Kalali; Edmund Howe
Journal:  Psychiatry (Edgmont)       Date:  2007-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.